Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1

Clinical Cancer Research

Volumn 4, Issue 1, 1998, Pages 235-240

  Aida, Hiroshi ^a   Takakuwa, Koichi ^a   Nagata, Hiroshi ^a   Tsuneki, Ikunosuke ^a   Takano, Masashi ^a   Tsuji, Shoji ^a   Takahashi, Takeshi ^b   Sonoda, Takahiko ^c   Hatae, Masayuki ^d   Takahashi, Katsuyuki ^e   Hasegawa, Kazuo ^f   Mizunuma, Hideki ^g   Toyoda, Nagayasu ^h   Kamata, Hiroyuki ⁱ   Torii, Yuichi ^j   Saito, Noriyasu ^k   Tanaka, Kohei ^l   Yakushiji, Michiaki ^m   Araki, Tsutomu ⁿ   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Niigata Cancer Center   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

^d Kagoshima City Hospital   (Japan)

^e SENDAI CITY MEDICAL CENTER   (Japan)

^f HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^g GUNMA UNIVERSITY   (Japan)

^h MIE UNIVERSITY   (Japan)

ⁱ TOCHIGI CANCER CENTER   (Japan)

^j SEIREI HAMAMATSU GENERAL HOSPITAL   (Japan)

^k Shonai Hospital   (Japan)

^l AKITA RED CROSS HOSPITAL   (Japan)

^m KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ Nihon Medical University Hospital   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER STAGING; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTADENOCARCINOMA; FEMALE; GENE MUTATION; GERM LINE; HUMAN; HUMAN TISSUE; JAPAN; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; SURVIVAL RATE;

EID: 0031881833     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigan, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bodgen, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barren, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266: 66-71, 1994.
2. Szabo, C. I., and King, M-C. Inherited breast and ovarian cancer. Hum. Mol. Genet., 4: 1811-1817, 1995.
3. Takano, M. Aida, H., Tsuneki, I., Takakuwa, K., Hasegawa, I., Tanaka, H., Saito, M., Tsuji, S., Sonoda, T., Hatae, M., Chen, J-T., Takahashi, K., Hasegawa, K., Toyoda, N., Saito, N., Yakushiji, M., Araki, T., and Tanaka, K. Mutational analysis of BRCA1 gene in ovarian cancer and breast-ovarian cancer families in japan. Jpn. J. Cancer Res., 88: 407-413, 1997.
4. Inoue, R., Fukutomi, T., Ushijima, T., Matsumoto, Y., Sugimura, T., and Nagao, M. Germ-line mutation of BRCA1 in Japanese breast cancer families. Cancer Res., 55: 3521-3524, 1995.
5. Katagiri, T., Emi, N., Ito, I., Kobayashi, K., Yoshimoto, M., Iwase, T., Kasumi, F., Miki, Y., Skolnick, M. H., and Nakamura, Y. Mutations in the BRCA1 gene in Japanese breast cancer patients. Hum. Mutat., 7: 334-339, 1996.
6. Parkin, M. D., Muir, S. C., Whelan, S. L., Gao, Y. T., Ferlay, J., and Powell, J. Cancer Incidence of Five Continents. IARC Sci. Publ. No. 120, pp. 301-501. Lyon, France: IARC, 1992.
7. Berry, D. A, Parmigiani, G., Sanchez, J., Schildkraut, J., and Winer, E. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J. Natl. Cancer Inst. (Bethesda), 89: 227-238, 1997.
8. Tominaga, H., Aoki, K., Hanai, A., and Kurihara, N. The Statistical Yearbook for Cancer, p. 159. Tokyo, Japan: Shinohara Press, 1993.
9. Rubin, S. C., Benjamin, I., Behbakht, K., Takahashi, H., Morgan, M. A., LiVolsi, V. A., Berchuck, A., Muto, M. G., Garber, J. E., Weber, B. L., Lynch, H. T., and Boyd, J. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N. Engl. J. Med., 335: 1413-1416, 1996.
10. Buller, R. E., Anderson, B., Connor, J. P., and Robinson, R. Familial ovarian cancer. Gynecol. Oncol., 51: 160-166, 1993.
11. Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephenson, L., Salerno, G., Conway, T. A., and Lynch, H. T. Hereditary breast cancer: pathobiology, prognosis, BRCA1 and BRCA2 gene linkage. Cancer (Phila.), 77: 697-709, 1996.
12. Ochiai, K., Sasaki, H., Terashima, Y., and Fukushima, M. Prognostic factor analysis and treatment results of ovarian cancer in Japan. Int. J. Technol. Assessment Health Care, 10: 406-425, 1994.
13. Sambrook, J., Fritsch, E. F., and Maniatis, T. Isolation of high-molecular-weight DNA from mammalian cells. In: Molecular Cloning: A Laboratory Manual, pp. 9.14-9.23. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
14. Kaplan, E., and Meier, P. Nonparametric estimation from incom-plete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
15. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
16. Kodama, S., and Tanaka, K. Today's stats (ovary). Ann. Cancer Res. Ther., 5: 75, 1996.
17. McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., and Davidson, M. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage and stage ovarian cancer. N Engl. J. Med., 334: 1-6, 1996.
18. Porter, D. E., Cohen, B. B., Wallace, M. R., Smyth, E., Chetty, U., Dixon, J. M., Steel, C. M., and Carter, D. C. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br. J. Surg., 81: 1512-1515, 1994.
19. Ottman, R., Pike, M. C., King, M. C., Casagrande, J. T., and Henderson, B. Familial breast cancer in a population-based series. Am. J. Epidemiol., 123: 15-21, 1986.
20. Easton, D. F., Bishop, D. T., Ford, D., Crockford, G. O., and the Breast Cancer Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet., 52: 678-701, 1993.
21. Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., and Brody, L. C. The carrier frequency of the BRCA1 185delAG mutation is approximately 1% in Ashkenazi Jewish individuals. Nat. Genet., 11: 198-200, 1995.
22. Stratton, J. F., Gayther, S. A., Russell, P., Dearden, J., Gore, M., Blake, P., Easton, D., and Ponder, B. A. J. Contribution of BRCA1 mutations to ovarian cancer. N. Engl. J. Med., 336: 1125-1130, 1997.
23. Matsushima, M., Kobayashi, K., Emi, M., Saito, J., Suzumori, K., and Nakamura, Y. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germ-line mutations, but no evidence of somatic mutation. Hum. Mol. Genet., 4: 1953-1956, 1995.